Clinical and prognostic factors associated with diagnostic wait times by breast cancer detection method

SpringerPlus

Volumn 3, Issue 1, 2014, Pages 1-10

  Plotogea, Amalia ^a,b   Chiarelli, Anna M ^a,b   Mirea, Lucia ^b,c   Prummel, Maegan V ^a   Chong, Nelson ^d   Shumak, Rene S ^a   O'Malley, Frances P ^e   Holloway, Claire Mb ^f   Boyd, Norman ^g   Chappell, Lynn ^h,i   Hey, Amanda ^j   Joanisse, Suzie ^k   McMullen, Alison ^l   Rand, Carol ^m   Van Manen, Lori ⁿ  

^a CANCER CARE ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h Erie St Clair Regional Cancer Program   (Canada)

ⁱ LONDON REGIONAL CANCER PROGRAM   (Canada)

^j Health Sciences North   (Canada)

^k OTTAWA REGIONAL CANCER CENTRE   (Canada)

^l Regional Cancer Care Northwest   (Canada)

^m JURAVINSKI CANCER CENTRE   (Canada)

ⁿ Southeast Regional Cancer Program   (Canada)

more..

Author keywords

Breast cancer; Diagnostic wait time; Interval cancers; Mammography; Screen detected cancers; Symptomatic cancers

Indexed keywords

EID: 84899566860     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-125     Document Type: Article

References (29)

1. American Joint Committee on Cancer (2002) Cancer staging manual, 6th edition. Springer-Verlag, New York, NY
2. Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yankeelov T, National Comprehensive Cancer Network. (2009) NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 7(10):1060-1096
3. Booth CM, Li G, Zhang-Salomons J, Mackillop WJ (2010) The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer 116(17):4160-4167
4. Brett J, Austoker J, Ong G (1998) Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment.J Public Health Med 20(4):396-403
5. Burgess CC, Ramirez AJ, Richards MA, Love SB (1998) Who and what influences delayed presentation in breast cancer? Br J Cancer 77(8):1343-1348
6. Burke JP, Power C, Gorey TF, Flanagan F, Kerin MJ, Kell MR (2008) A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer. Eur J Surg Oncol 34(2):149-153
7. Burrell HC, Sibbering DM, Wilson AR, Pinder SE, Evans AJ, Yeoman LJ, Elston CW, Ellis IO, Blamey RW, Robertson JF (1996) Screening interval breast cancers: mammographic features and prognosis factors. Radiology 199(3):811-817
8. Caplan LS, May DS, Richardson LC (2000) Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health 90(1):130-134
9. Chiarelli AM, Mai V, Halapy EE, Shumak RS, O'Malley FP, Klar NS (2005) Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program. Can J Public Health 96(4):259-263
10. Chiarelli AM, Halapy E, Nadalin V, Shumak R, O'Malley F, Mai V (2006) Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000. Eur J Cancer Prev 15(1):34-42
11. Chiarelli AM, Edwards SA, Sheppard AJ, Mirea L, Chong N, Paszat L, Shumak RS, O'malley FP (2012) Favourable prognostic factors of subsequent screen detected breast cancers among women 50 to 69. Eur J Cancer Prev. Epub 2012 Jan 23
12. Decker KM, Harrison M, Chateau D (2004) Influence of direct referrals on time to diagnosis after an abnormal breast screening result. Cancer Detect Prev 28(5):361-367
13. Dillon MF, Hill AD, Quinn CM, O'Doherty A, Crown J, Fleming FJ, McDermott EW, O'Higgins N (2004) Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer. J Med Screen 11(3):130-134
14. Downing A, Prakash K, Gilthorpe MS, Mikeljevic JS, Forman D (2007) Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer. Br J Cancer 96(5):836-840
15. Ganry O, Peng J, Dubreuil A (2004) Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma. J Med Screen 11(1):28-31
16. Gorin SS, Heck JE, Cheng B, Smith SJ (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166(20):2244-2252. doi:10.1001/archinte.166.20.2244
17. Holloway CM, Saskin R, Brackstone M, Paszat L (2007) Variation in the use of percutaneous biopsy for diagnosis of breast abnormalities in Ontario. Ann Surg Oncol 14(10):2932-2939. doi:10.1245/s10434-007-9362-3
18. Holowaty EJ, Marrett LD, Fehringer G (1995) Methods cancer incidence in Ontario: trends and regional variations in the 1980s. Publications Ontario, Toronto, Ontario
19. McCready D, Holloway C, Shelley W, Down N, Robinson P, Sinclair S, Mirsky D, Breast Cancer Disease Site Group of Cancer Care, Ontario's Program in Evidence-Based Care (2005) Surgical management of early stage invasive breast cancer: a practice guideline. Can J Surg 48(3):185-194
20. Olivotto IA, Kan L, King S (2000) Waiting for a diagnosis after an abnormal screening mammogram. SMPBC diagnostic process workgroup. Screening mammography program of British Columbia. Can J Public Health 91(2):113-117
21. Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, Kan L, Mirsky D, Sabine MJ, McGilly R, Caines JS (2001) Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. Can Med Assoc J 165(3):277-283
22. Olivotto IA, Gomi A, Bancej C, Brisson J, Tonita J, Kan L, Mah Z, Harrison M, Shumak R (2002) Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 94(8):2143-2150
23. Quan ML, Shumak RS, Majpruz V, Holloway C, O'Malley FP, Chiarelli AM (2012) Improving work up of the abnormal mammogram through organized assessment: results from the Ontario breast screening program. J Oncol Pharm Pract 8(2):107-112
24. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA (1999) Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 353(9159):1127-1131
25. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353(9159):1119-1126
26. Rimer BK, Bluman LG (1997) The psychosocial consequences of mammography. J Natl Cancer Inst Monogr 22:131-138
27. SAS Institute Inc (2008) Statistical analysis software 9.2 edn. SAS Institute, Cary NC
28. Schroen AA, Wobbes T, van der Sluis RF (1996) Interval carcinomas of the breast: a group with intermediate outcome. J Surg Oncol 63(3):141-144
29. Sutton S, Saidi G, Bickler G, Hunter J (1995) Does routine screening for breast cancer raise anxiety?Results from a three wave prospective study in England. J Epidemiol Community Health 49(4):413-418